Navamedic ASA

Carnegie Investment Bank acted as Joint Bookrunner in connection with the NOK 95 million placing of shares in Navamedic ASA.

Ingerø Reiten Investment Company sold approximately 3 million shares in the Company (equal to approx. 17% of the Company’s outstanding shares) at NOK 32 per share, through an accelerated bookbuilding after close of markets on 12 March 2024.

Thank you to Ingerø Reiten Investment Company for the vote of confidence in connection with the successful transaction.

Related articles

Schibsted
Investment Banking

Schibsted

Acquisition of 9.99% in FINN – NOK 2.5 billion Carnegie Investment Bank acted as financial advisor to...

BerGenBio ASA
Investment Banking

BerGenBio ASA

Carnegie Investment Bank is proud to have acted as manager in the exercise of warrants in...

Oncoinvent AS
Investment Banking

Oncoinvent AS

Carnegie Investment Bank is proud to have acted as Joint Bookrunner in connection with Oncoinvent AS’ NOK...